Healthcare DIVE March 18, 2020
Growth in value-based payment arrangements for medical devices is expected to accelerate as regulatory constraints ease and better analytics are developed for tracking outcomes, according to research out this month from the Deloitte Center for Health Solutions.
The healthcare system’s relentless cost pressures, combined with growing interest in proving value through improved clinical outcomes and reducing hospital readmissions, are driving demand for new types of contracts based on financial risk-sharing or product performance. Consolidating health systems have more purchasing power, and value committees at hospitals are increasingly selective about which technologies they buy.
“Most of the clients I’m working with are either considering or planning to implement these models,” said co-author Jay Zhu, a managing director at Deloitte.
Based on...
Today's Sponsors
Today's Sponsor